Infinity Pharmaceuticals CEO Discusses Cancer Drugs

April 5 (Bloomberg) -- Adelene Perkins, chief executive officer Infinity Pharmaceuticals Inc., and Simos Simeonidis, an analyst with Cowen & Co., talk about the outlook for targeted cancer drugs. They speak with Pimm Fox on Bloomberg Television's "Taking Stock." Bloomberg's Meg Tirrell also speaks. (Source: Bloomberg)

S&P Says Toshiba May Be Cut Further
36:41 - S&P Global Ratings Corporate Ratings Director Hiroki Shibata discusses his outlook for Toshiba. He speaks on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
  • Hoover Inst.'s Chen Says Trump Still Has a Lot to Learn
  • Full Show: What'd You Miss? (03/28)
  • China Aims to Cut Coal Imports in Shift to Cleaner Energy